相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Prospective Multicenter Study Evaluating Fecal Calprotectin in Adult Acute Bacterial Diarrhea
Yogesh M. Shastri et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
Michael Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease
Thomas R. Walker et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease
Kaija-Leena Kolho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis
J Langhorst et al.
INFLAMMATORY BOWEL DISEASES (2005)
Endoscopy in inflammatory bowel diseases
DW Hommes et al.
GASTROENTEROLOGY (2004)
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Fecal lactoferrin: A new parameter to monitor infliximab therapy
S Buderus et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Role of faecal calprotectin as non-invasive marker of intestinal inflammation
F Costa et al.
DIGESTIVE AND LIVER DISEASE (2003)
Review article: Crohn's disease: monitoring disease activity
R Sostegni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
JA Tibble et al.
GASTROENTEROLOGY (2002)
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
E Aadland et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble et al.
GUT (2000)
Improved assay for fecal calprotectin
H Ton et al.
CLINICA CHIMICA ACTA (2000)
分享论文
